Stockscreener 앱 받기
2.26
2.37%
-0.07
전일 마감가:
$2.33
열려 있는:
$2.33
하루 거래량:
2,789
Relative Volume:
0.00
시가총액:
$5.18M
수익:
$2.54M
순이익/손실:
$-4.13M
주가수익비율:
-0.8218
EPS:
-2.75
순현금흐름:
$-4.11M
1주 성능:
-7.65%
1개월 성능:
-12.51%
6개월 성능:
-18.76%
1년 성능:
-44.63%
1일 변동 폭
$2.254
$2.33
1주일 범위
$2.25
$2.6398
52주 변동 폭
$2.20
$13.93
Xenetic Biosciences Inc Stock (XBIO) Company Profile
명칭
Xenetic Biosciences Inc
전화
781-778-7720
주소
945 CONCORD ST., FRAMINGHAM, MA
XBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.26 | 5.34M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.25 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.62 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
847.66 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.11 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.33 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-01-08 | 개시 | Maxim Group | Buy |
Xenetic Biosciences Inc 주식(XBIO)의 최신 뉴스
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - The Florida Times-Union
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform - Enterprise News
Value Recap: Will Xenetic Biosciences Inc stock attract more institutional investorsMarket Performance Report & Verified Technical Signals - moha.gov.vn
Xenetic Biosciences adjourns 2025 annual meeting - MSN
Xenetic Biosciences Adjourns 2025 Annual Meeting - TipRanks
Xenetic Biosciences (NASDAQ: XBIO) Resets 2025 Annual Meeting to Jan. 8, 2026 - Stock Titan
Can Xenetic Biosciences Stock Recover If Markets Fall? - Trefis
EBITDA per share of Xenetic Biosciences, Inc. – BER:3XB0 - TradingView
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock - SouthCoastToday.com
Will Xenetic Biosciences Inc. stock keep outperforming rivals2025 Buyback Activity & Risk Controlled Stock Alerts - Newser
Published on: 2025-12-05 14:51:47 - moha.gov.vn
Is Xenetic Biosciences Inc. (3XB0) stock a top hedge fund pick2025 Top Gainers & Reliable Volume Spike Trade Alerts - Newser
Is Xenetic Biosciences Inc. (3XB0) stock a buy for dividend portfoliosWeekly Stock Report & Real-Time Sentiment Analysis - Newser
Xenetic Biosciences, Inc. (XBIO) Jumps 10% in Pre-market: What’s Driving the Move? - Stocks Telegraph
Can Xenetic Biosciences Inc. (3XB0) stock reach $200 price targetJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Is Xenetic Biosciences Inc. (3XB0) stock a fit for income portfoliosEarnings Beat & Technical Pattern Alert System - Newser
Is Xenetic Biosciences Inc. (3XB0) stock bottoming after sell offWeekly Trade Summary & Weekly Hot Stock Watchlists - Newser
Xenetic Biosciences (XBIO) Stock Analysis Report | Financials & Insights - Benzinga
What analysts say about Xenetic Biosciences Inc stockPortfolio Diversification Tips & Exceptional Profit Trading - earlytimes.in
Published on: 2025-11-28 02:47:25 - BỘ NỘI VỤ
Xenetic Biosciences Inc. (XBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Xenetic Biosciences Inc. (3XB0) stock prepared for digital transitionJuly 2025 Selloffs & Trade Opportunity Analysis Reports - newser.com
How Xenetic Biosciences Inc. (3XB0) stock reacts to weak economyJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Is Xenetic Biosciences Inc. forming a reversal patternJuly 2025 Rallies & Safe Capital Allocation Plans - newser.com
Is Xenetic Biosciences Inc. stock bottoming outJuly 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Long term hold vs stop loss in Xenetic Biosciences Inc.Quarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Xenetic Biosciences Inc (XBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
0.32%
자본화:
|
볼륨(24시간):